MAGE-G1 Activators
MAGE-G1 activators belong to a class of chemical agents designed to modulate the activity of MAGE-G1, a protein encoded by the MAGE-G1 gene, which is part of a broader family known as melanoma-associated antigens (MAGE). The MAGE family is known for the wide range of functions they play within cellular processes, including gene expression regulation, cell cycle progression, and other critical intracellular signaling pathways. MAGE-G1 activators specifically target the regulatory functions of the MAGE-G1 protein. These activators can bind to the MAGE-G1 protein or influence its expression or post-translational modifications, which, in turn, affects the protein's ability to interact with other cellular components. The precise mechanism of action can vary depending on the molecular structure of the activator compound, which is often tailored to interact with the unique features of the MAGE-G1 protein's binding sites or other regulatory regions.
The development and study of MAGE-G1 activators require an in-depth understanding of the protein's structure and function within cells. These molecules often emerge from high-throughput screening processes, where a vast number of potential activators are tested for their ability to affect MAGE-G1. Some activators may work by enhancing the natural activity of MAGE-G1, while others may promote the stabilization of the protein, prolonging its presence and function within the cell. The biochemical interactions facilitated by MAGE-G1 activators are typically complex, involving not only direct binding to the target protein but also influencing the broader proteomic and genomic landscape of the cell. Understanding the specific interactions between MAGE-G1 activators and their target, as well as the subsequent cellular outcomes, is central to elucidating the role of these chemical agents in the intricate web of cellular processes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin increases intracellular cAMP levels, which can indirectly enhance the activity of MAGE-G1 by activating PKA. PKA phosphorylation can affect proteins that are part of the MAGE-G1-related pathways, leading to its functional activation. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a kinase inhibitor that can enhance MAGE-G1 activity by inhibiting kinases that negatively regulate pathways associated with MAGE-G1 function, thus allowing more robust activity of MAGE-G1-related cellular processes. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that raises intracellular calcium levels, potentially enhancing MAGE-G1 activity by activating calcium-dependent signaling pathways that MAGE-G1 may be involved in. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a PKC activator that can enhance the activity of MAGE-G1 by modulating signaling pathways in which MAGE-G1 is implicated, as PKC phosphorylation of proteins can impact MAGE-G1-related functions. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can enhance MAGE-G1 activity by disrupting PI3K/Akt signaling, which may relieve negative feedback on pathways where MAGE-G1 is operative, thereby potentiate MAGE-G1-related signaling. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum kinase inhibitor that, despite general inhibition, could selectively enhance MAGE-G1 activity by inhibiting kinases that negatively regulate MAGE-G1-associated pathways. | ||||||
Capsaicin | 404-86-4 | sc-3577 sc-3577C sc-3577D sc-3577A | 50 mg 250 mg 500 mg 1 g | $96.00 $160.00 $240.00 $405.00 | 26 | |
Capsaicin activates TRPV1 channels, which can lead to enhanced MAGE-G1 activity through downstream signaling pathways involving calcium influx, potentially impacting biological processes where MAGE-G1 is relevant. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol activates SIRT1, which can enhance MAGE-G1 activity by modulating signaling pathways that are influenced by SIRT1 activity, including those where MAGE-G1 may function. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin has multiple biological targets and can enhance MAGE-G1 activity by modulating NF-κB signaling, which in turn could influence cellular processes that MAGE-G1 is involved in. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a PDE4 inhibitor that increases cAMP levels, potentially enhancing MAGE-G1 activity by cAMP-dependent pathways, including PKA signaling, which could affect MAGE-G1-related functions. | ||||||